Gossamer Bio Announces First Quarter 2025 Financial Results and Provides Business Update, Including Closure of New Patient Screening in Phase 3 PROSERA Study
Stock Information for Gossamer Bio Inc.
Loading
Please wait while we load your information from QuoteMedia.